The evidence for NME being involved in PD etiology has further been strengthened by the identification of PD-specific SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in the Chinese population [24] and of the variant of SLC41A1 carrying the amino acid substitution p.A350V (c.1049C>T) in one PD patient of Caucasian origin [23]. The gene discussed is SLC41A1; the disease is Parkinson disease.